"/> Invitrogen™ Peptide synthétique PD-L1 humain | B-LABO France

Invitrogen™ Peptide synthétique PD-L1 humain

Réf. : BL-RE-175807Réf. fabricant : 15296669 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
29126
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q9NZQ7
Nom usuel
Human PD-L1
Marque
Invitrogen

PDL-1 Synthetic Peptide, PEP-0463, from Invitrogen.

Programmed death receptor ligand 1 (PD-L1, also called B7-H1) is a recently described B7 family member. To date, one specific receptor has been identified that can be ligated by PD-L1. This receptor, programmed death receptor 1 (PD-1), has been shown to negatively regulate T-cell receptor (TCR) signaling. Upon ligating its receptor, PD-L1 has been reported to decrease TCR-mediated proliferation and cytokine production. PD-L1 expression was found to be abundant on many murine and human cancers and could be further up-regulated upon IFN-gamma stimulation. Thus, PD-L1 might play an important role in tumor immune evasion.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-175807
Réf. fabricant15296669
Gene ID (Entrez)29126
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ9NZQ7
Nom usuelHuman PD-L1
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)CD274
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.